Michael John Kazley

Insider Reports History

Location
Miami Beach, FL
Signature
/s/ Michael Kazley
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Sponsored

Holdings reported by Michael John Kazley:

Company Role Class Num Shares Value Price $ Report Date Ownership
NovaBay Pharmaceuticals, Inc. Chief Executive Officer, Director, 10%+ Owner Common Stock 56,806,080 $74,228,504 $1.31 21 Oct 2025 By R01 Entities
Stablecoin Development Corp Chief Executive Officer, Director, 10%+ Owner Restricted Stock Units (Performance-Based) 7,722,802 31 Mar 2026 Direct
Stablecoin Development Corp Chief Executive Officer, Director, 10%+ Owner Restricted Stock Units (Time-Based) 4,118,828 31 Mar 2026 Direct
NovaBay Pharmaceuticals, Inc. Chief Executive Officer, Director, 10%+ Owner Pre-Funded Warrants (Right to Buy) 2,702,703 16 Oct 2025 By R01 Entities
NovaBay Pharmaceuticals, Inc. Chief Executive Officer, Director, 10%+ Owner Series D Non-Voting Convertible Preferred Stock 220,663 16 Oct 2025 By R01 Entities
NovaBay Pharmaceuticals, Inc. Chief Executive Officer, Director, 10%+ Owner Series E Non-Voting Convertible Preferred Stock 134,375 16 Oct 2025 By R01 Entities

Insider Reports Filed by Michael John Kazley

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NBY Stablecoin Development Corp 31 Mar 2026 2 $0 4 Chief Executive Officer, Director, 10%+ Owner 02 Apr 2026, 21:44
NBY NovaBay Pharmaceuticals, Inc. 16 Oct 2025 2 $0 4 Chief Executive Officer, Director, 10%+ Owner 03 Nov 2025, 21:38
NBY NovaBay Pharmaceuticals, Inc. 16 Oct 2025 2 $0 4 Chief Executive Officer, Director, 10%+ Owner 20 Oct 2025, 21:40
NBY NovaBay Pharmaceuticals, Inc. 16 Oct 2025 0 $0 3 Chief Executive Officer, Director, 10%+ Owner 20 Oct 2025, 21:38

Sponsored